Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Exclusive. Ozempic Victims: a Class Action Lawsuit Is Being Prepared, a First in France

Summary by ledauphine.com
A class-action lawsuit against Novo Nordisk, the manufacturer of Ozempic, is being prepared. Patients are alleging serious side effects caused by this antidiabetic drug, which has been misused for cosmetic purposes to achieve weight loss. The lawsuit is expected to be filed this year in Paris—a first in France.

4 Articles

leprogres.frleprogres.fr
+2 Reposted by 2 other sources
Center

Health. Ozempic: Nearly 400 Serious Cases Recorded in France in Less than Two Years

According to the ANSM (French National Agency for Medicines and Health Products Safety), 376 serious cases and 19 deaths occurred between 2023 and 2025 after taking antidiabetic drugs used to treat obesity (Ozempic, Wegovy, etc.). This figure is likely an underestimate: not all patients report their symptoms.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

bienpublic.com broke the news in on Monday, February 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Diabetes icon

Diabetes

Obesity icon

Obesity

Health icon

Health

Ozempic icon

Ozempic

Paris, France icon

Paris, France

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal